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Rapid development of the nano technology 
industry is resulting in the production of a 
variety of engineered nano materials (ENMs) 
for structural support, electronics, energy, 
medi cal imaging, and drug delivery, as 
well as other applications. Although nano-
technology offers enormous potential soci-
etal benefits, concerns have been raised about 
the safety of ENM-containing products in 
regard to human and environmental health. 
Cumulative evidence suggests that some 
ENMs may exert adverse effects on the lung 
and other organ systems (Xia et al. 2009). 
These potential risks must be addressed in 
order to develop safe nano technology, but 
setting and implementing exposure stan-
dards require predictable results proven reli-
able by repeatability and agreement among 
multiple investigators. Because of the lack of 
standard protocols and reagents, ENM toxic-
ity studies are difficult to compare because 
of inconsistencies in health outcomes and/
or toxic thresholds. Much of this discordance 
can be attributed to a) heterogeneity of ENMs 
from batch to batch; b) inherent difficulties 
of inter laboratory comparisons; c) agglomera-
tion of particles, which often changes toxicity; 
d) method and duration of dosing and dose 
level; and e) method of ENM manipulation 
prior to testing.
In addition to dose, many factors influ-
ence the toxicity of ENMs, including surface 
characteristics, charge, and shape. Size alone is 
a major determinant because many bulk mate-
rials that are relatively inert become toxic when 
produced at the nano scale (Borm et al. 2006; 
Nel et al. 2006). Commonly produced and 
high production volume ENMs are carbon-
based (e.g., nano tubes, graphene, fullerenes), 
metal-based [e.g., gold, silver, quantum dots, 
titanium dioxide (TiO2), zinc oxide], or of a 
biologic nature (e.g., liposomes and viruses 
designed for gene or drug delivery) (Card et al. 
2008). Which ENMs will present the great-
est potential threat to human health depends 
on relative toxicity and on the potential for 
exposure. TiO2 is one of the most widely used 
nano scale materials to date, and the conversion 
of bulk to nano scale TiO2 in consumer prod-
ucts (e.g., sunscreens) and industrial products 
(e.g., paints) is rapidly increasing (Robichaud 
et al. 2009). From a human health standpoint, 
this is significant because bulk TiO2 nano-
particles demon strate increased toxicity com-
pared with larger TiO2 particles (Oberdörster 
et al. 2005). Moreover, TiO2 nano particles 
can be manipulated into wire and belt shapes. 
The production of multi walled carbon nano-
tubes (MWCNTs) is also increasing rapidly, 
along with a diversity of manipulations to 
alter physi cal and chemical attributes for vari-
ous applications in industry, electronics, and 
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Background: Engineered nanomaterials (ENMs) have potential benefits, but they also present 
safety concerns for human health. Inter laboratory studies in rodents using standardized protocols 
are needed to assess ENM toxicity. 
Methods: Four laboratories evaluated lung responses in C57BL/6 mice to ENMs delivered by 
oropharyngeal aspiration (OPA), and three labs evaluated Sprague-Dawley (SD) or Fisher 344 
(F344) rats following intratracheal instillation (IT). ENMs tested included three forms of titanium 
dioxide (TiO2) [anatase/rutile spheres (TiO2-P25), anatase spheres (TiO2-A), and anatase nanobelts 
(TiO2-NBs)] and three forms of multiwalled carbon nanotubes (MWCNTs) [original (O), puri-
fied (P), and carboxylic acid “functionalized” (F)]. One day after treatment, broncho alveolar lavage 
fluid was collected to determine differential cell counts, lactate dehydrogenase (LDH), and protein. 
Lungs were fixed for histopathology. Responses were also examined at 7 days (TiO2 forms) and 
21 days (MWCNTs) after treatment. 
results: TiO2-A, TiO2-P25, and TiO2-NB caused significant neutrophilia in mice at 1 day in 
three of four labs. TiO2-NB caused neutrophilia in rats at 1 day in two of three labs, and TiO2-P25 
and TiO2-A had no significant effect in any of the labs. Inflammation induced by TiO2 in mice 
and rats resolved by day 7. All MWCNT types caused neutrophilia at 1 day in three of four mouse 
labs and in all rat labs. Three of four labs observed similar histo pathology to O-MWCNTs and 
TiO2-NBs in mice.
conclusions: ENMs produced similar patterns of neutrophilia and pathology in rats and mice. 
Although inter laboratory variability was found in the degree of neutrophilia caused by the three types 
of TiO2 nano particles, similar findings of relative potency for the three types of MWCNTs were 
found across all laboratories, thus providing greater confidence in these inter laboratory comparisons.
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medicine. Several studies have already shown 
that some types of MWCNTs delivered to the 
lungs by inhala tion, intra tracheal instilla tion 
(IT), or oro pharyngeal aspiration (OPA) cause 
inflammation and fibrosis (Bonner 2010).
The goal of the Nano GO Consortium, 
an inter laboratory, multi investigator proj-
ect, was to determine whether independent 
investigators involved in National Institute 
of Environmental Health Sciences (NIEHS)-
funded consortium studies could generate 
consistent data sets in rodents using a well-
characterized and commonly sourced panel of 
ENMs (Xia et al. 2013) and harmonized proto-
cols for nano particle dispersion, delivery to the 
lungs, and collection of tissues. ENMs tested by 
this consortium included TiO2 anatase/rutile 
nano spheres (TiO2-P25), 100% anatase spheres 
(TiO2-A), and anatase nano belts (TiO2-NBs), 
as well as three different MWCNTs, including 
the original material (O-MWCNT), a purified 
form with partial metal removal (P-MWCNT), 
and a carboxylic acid–functionalized form 
(F-MWCNT). Four laboratories evaluated 
lung responses in C57BL/6 mice exposed 
to ENMs by OPA exposure, and three labs 
tested responses in Sprague-Dawley (SD) or 
Fischer 344 (F344) rats following IT exposure. 
The results presented here demonstrate that 
a standard protocol can be used across mul-
tiple labs to yield similar results in the pulmo-
nary inflammatory response. We also make 
recom mendations for future directions in test-
ing ENMs in a harmonized fashion among 
multiple labs. These recom mendations should 
serve to guide regulatory agencies in making 
decisions regarding standard setting for occupa-
tional and environ mental exposures to ENMs 
that present potential risks to human health 
and the environ ment. 
Materials and Methods
ENMs. The physical and chemi cal charac-
teristics of nano particles used in this study 
are described in detail by Xia et al. (2013). 
We used three different formulations of 
TiO2 nano particles: TiO2-P25, TiO2-A, 
and TiO2-NBs. We obtained the TiO2-A 
from P. Biswas (Department of Energy, 
Environmental & Chemical Engineering, 
Washington University, St. Louis, MO); 
TiO2-P25 nano particles from Evonik 
(Essen, Germany); TiO2-NBs from N. Wu 
(Mechanical and Aerospace Engineering, 
West Virginia University, Morgantown, 
WV); MWCNTs from S. Mitra (Department 
of Chemistry and Environmental Science, 
New Jersey Institute of Technology, Newark, 
NJ); O-MWCNT from CheapTubes, Inc. 
(Brattleboro, VT). Two modified forms of 
O-MWCNTs were tested: P-MWCNT was 
derived from O-MWCNT by acid purifica-
tion to remove residual metal catalyst, and 
F-MWCNT was derived from O-MWCNT 
by the addition of –COOH groups via carbox-
ylic acid treatment to the nano tube surface. 
Preparation of ENM suspensions. ENMs 
were suspended in dispersion medium (DM) 
containing disatu rated phosphatidyl choline 
in 100% ethanol (DSPC; Sigma-Aldrich, 
St. Louis, MO); rat, mouse, or bovine serum 
albumin (Sigma-Aldrich); and 0.9% sterile 
saline (Porter et al. 2008). Spherical TiO2 
nano particle and MWCNT suspensions were 
dispersed using a cup-horn sonicator (three 
mouse labs) for 1 min or a probe sonicator 
(rat labs and one mouse lab) for 30 min using 
a 10-sec on/off duty cycle and ice bath to dis-
perse the particles and ensure that the sample 
temperature did not exceed 28°C. TiO2-NBs 
were not sonicated because preliminary stud-
ies showed that this causes axial fractures. 
Instead, TiO2-NBs were suspended in DM 
using gentle mechanical stirring for 60 min at 
room temperature. Control animals received 
DM alone that had been sonicated/stirred as 
described above. 
Consortium labs. Four labs evaluated the 
lung responses of C57BL/6 mice exposed 
to ENMs by OPA exposure, and three labs 
tested responses in SD or F344 rats using IT 
exposure. There were four mouse lab groups: 
North Carolina State University (ML1), 
East Carolina University (ML2), Michigan 
State University (ML3), and University of 
Washington (ML4). There were three rat lab 
groups: National Institute for Occupational 
Safety and Health (RL1; SD rats), University 
of California, Davis (RL2; SD rats), and 
University of Rochester (RL3; F344 and SD 
rats). Lab codes were randomly assigned, and 
no identification is implied here. The first 
round of in vivo studies involved three inde-
pendent labs, all of which used SD rats that 
were exposed to either TiO2-P25 or TiO2-A in 
DM. None of the treatment groups reported 
statistically significant changes in lung inflam-
matory parameters relative to DM controls; 
therefore, the scope of the consortium stud-
ies was expanded to include another rat strain 
(F344) and another species (mouse, C57BL6). 
The goal of this expansion was to strengthen 
conclusions about the relative toxicity of the 
selected ENMs that were evaluated. 
Experimental design. ENMs (10, 20, or 
40 µg in 50 µL DM) were delivered to the 
lungs of 6- to 8-week-old male C57BL/6 
mice (20–25 g body weight) via OPA. TiO2 
particles (20, 70, or 200 µg in 250 µL DM) 
or MWCNTs (10, 50, or 200 µg in 250 µL 
DM) were delivered to the lungs of 8- to 
10-week-old male SD and F344 rats (350–
420 g body weight) via IT. Lung tissues and 
bronchoalveolar lavage fluid (BALF) were col-
lected at 1 and 7 days after exposure to TiO2 
nano particles and 1 and 21 days after expo-
sure to MWCNTs. BALF samples (three per 
mouse and five per rat) for each animal were 
combined and evaluated for total and differen-
tial cell counts [macro phages, neutro phils, 
eosino phils, and lympho cytes] and for mea-
surement of total protein concentration and 
lactate dehydrogenase (LDH) activity. Total 
cell numbers were determined by counting the 
cells on three non overlapping images taken at 
20× magnification, and the percentage of cell 
type per total cell population was determined 
by counting 500 cells per sample. For histo-
pathological analysis, tissue sections from the 
left lung lobe were stained with hematoxylin 
and eosin (H&E). Immunohistochemistry was 
performed on tissue sections using a mono-
clonal rat anti-mouse neutrophil (allotypic 
marker clone 7/4) antibody (AbD Serotec, 
Raleigh, NC). Additional details are provided 
in Supplemental Material, Supplemental 
Methods and Materials, pp. 3–4 (http://
dx.doi.org/10.1289/ehp.1205693). We pres-
ent values as the percentage of neutrophils 
because it is not possible to compare effects 
of ENMs across labs or species using abso-
lute neutrophil numbers as a result of variabil-
ity related to lung size and lavage technique. 
All animals were treated humanely and with 
regard for alleviation of suffering.
Statistical analysis. Data are presented as 
mean ± SE for groups of four to six mice or 
rats. We performed two-way analyses of vari-
ance (ANOVA) and post hoc Tukey’s test 
or post hoc Bonferroni t-test. The analyses 
considered the main effects of and inter-
actions between the factors, dose, and lab. 
In many cases, the two-way interaction was 
not statistically significant, so independent 
one-way analy ses were performed. We con-
sidered p ≤ 0.05 to be statistically significant. 
Statistical analyses were performed using 
Graphpad Prism 5 (Graphpad Software, 
LaJolla, CA) and SigmaPlot 11 (Systat 
Software Inc., San Jose, CA). 
Results
Mice. TiO2. Differential counting of cells 
retrieved in BALF showed that all TiO2 
ENMs tested increased the percentage of 
neutro phils relative to other cell types (macro-
phages, lympho cytes, and eosino phils). 
Results are shown only for the highest dose 
(40 µg/50 µL) because no significant effect 
on lung inflammation was observed at the 
lower doses. At 1 day post exposure, the rela-
tive percentage of neutro phils was signifi-
cantly increased by TiO2-P25 in two of four 
labs (Figure 1A), by TiO2-A in one of four 
labs (Figure 1B), and by TiO2-NB in three of 
four labs (Figure 1C). By day 7 post exposure, 
neutrophilic inflammation in all TiO2 treat-
ment groups returned to nearly baseline lev-
els. Macrophages comprised > 95% of total 
BALF cells retrieved from the lungs of con-
trol mice (exposed to DM alone) (data not 
shown). TiO2 nano particles did not cause 
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significant increases in the relative percent-
ages of lymphocytes or eosinophils, except 
for a slight increase in the relative percent-
age of eosinophils observed by one lab after 
treatment with TiO2-NB (data not shown). 
BALF cyto spins confirmed that inflammation 
caused by nano particle exposure was due pri-
marily to neutro phil influx (data not shown). 
All four mouse labs observed that TiO2-NB 
caused an inflammatory response at the ter-
minal bronchio lar region and the alveolar 
duct bifurcation region of the distal lung in 
mice 1 day after OPA delivery (Figure 2). 
TiO2-NBs were easily detectable by polarized 
light microscopy and were localized primarily 
in alveolar macro phages.
MWCNTs. Differential cell counts 
showed that the percentages of neutro phils 
were increased relative to other cell types in 
mouse BALF at 1 day post exposure to all forms 
of MWCNTs (O-MWCNT, P-MWCNT, 
and F-MWCNT) at 40 µg/50 µL (Figure 3). 
Lower doses of MWCNTs caused no signifi-
cant effects on neutrophilia. In mice treated 
with MWCNTs, no significant increases 
were observed in the relative percentages of 
lympho cytes or eosino phils (data not shown). 
Light microscopic images of BAL cyto-
spins confirmed that changes in the relative 
percentage of BAL cells were due to a sig-
nificant increase in neutrophils produced by 
treatment with MWCNTs (data not shown). 
O-MWCNTs caused the greatest increases 
in neutrophils at 1 day post exposure in three 
of four labs compared with P-MWCNTs 
and F-MWCNTs (Figure 3). The inflamma-
tory responses to all MWCNTs subsided to 
control levels by 21 days post exposure (data 
not shown). Combining the data from the 
four labs demonstrated the following order 
of potency: O-MWCNTs > P-MWCNTs 
> F-MWCNTs, albeit not to a significant 
extent [see Supplemental Material, Figure S1 
(http://dx.doi.org/10.1289/ehp.1205693)]. 
However, combining the data from three of the 
four labs (ML1, ML2, and ML3) that initially 
showed significant effects of MWCNTs on 
neutrophils demon strated a significant differ-
ence between O-MWCNTs and F-MWCNTs 
(see Supplemental Material, Figure S1). All four 
labs demon strated that total protein and LDH 
levels in BALF were increased by all forms of 
MWCNTs or TiO2 nano particles, although 
these two end points of lung injury were highly 
variable among labs (data not shown).
Histopathological analysis was used to 
determine the site of deposition of MWCNTs 
and the type of inflammatory lesions caused 
by oropharyngeal exposure to MWCNTs. 
Figure 4A shows that O-MWCNTs delivered 
by OPA caused centri acinar bronchiolitis/
alveolitis in mice in three of four labs (ML1, 
ML2, and ML3). One lab (ML4) observed 
O-MWCNTs primarily within alveolar ducts 
with little inflammation. In ML4, far fewer 
O-MWCNTs appeared to be delivered to 
the lungs (Figure 4A), which correlated with 
Figure 1. Stimulation of neutrophilic inflammation in the lungs of C57BL/6 mice by TiO2-P25 (A), TiO2-A (B), or TiO2-NB (C) evaluated in four labs (ML1, ML2, ML3, 
and ML4). Values are the mean ± SE percentage of neutro phils in BALF 1 day after exposure to DM only (control) or TiO2 ENMs at 40 µg/50 µL. 
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Figure 2. Photomicrographs of H&E-stained lung tissue 1 day after exposure of C57BL/6 mice to DM alone 
(control; A, D, G, J) or TiO2-NB at 40 μg/50 µL DM (B, C, E, F, H, I, K, L). Photomicrographs are representa-
tive sections from each of the four labs: (A–C) ML1, (D–F) ML2, (G–I) ML3, and (J–L) ML4. (A, D, G, J, B, 
E, H, K) Bright-field light microscopy of representative sections of lung from control mice (A, D, G, J) and 
TiO2-NB–exposed mice (B, E, H, K); sections from TiO2-NB–exposed mice show inflammatory lesions 
primarily localized to alveolar duct bifurcations. (C, F, I, L) Polarized light microscopy of the same images 
shown in B, E, H, and K show inflammation at an alveolar duct bifurcation. Abbreviations: a, alveolus; ad, 
alveolar ducts; bv, blood vessel; e, airway epithelium; tb, terminal bronchioles. Arrows indicate TiO2-NBs 
within macrophages at alveolar duct bifurcations, and asterisks (*) indicate inflammatory foci. All photo-
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much lower percentages of neutrophils recov-
ered from the mice in that lab (Figure 3A). 
The inflammatory response associated with 
MWCNT exposure was charact erized by 
neutrophilia as determined by BALF cell dif-
ferentials (Figure 4B) and by using immuno-
histochemical staining with an anti-neutrophil 
antibody, which revealed neutrophils near ter-
minal bronchioles and in proximity to macro-
phages containing O-MWCNTs (Figure 4C).
Rats. TiO2. Neither of the spherical TiO2 
nano particles—TiO2-P25 nor TiO2-A—
caused dose-related changes in the percentage 
of BALF neutrophils in rats in any of the labs, 
whereas TiO2-NBs caused significant neutro-
philia in a dose-dependent manner in two of 
three labs (Figure 5A–C). However, there were 
visible TiO2 inclusions in macro phages recov-
ered in BALF from exposed rats, indicating 
that TiO2 nano spheres reached the distal lung 
after IT. By day 7, all responses had returned 
to control values. No significant differences 
were observed between control (DM only) and 
TiO2-exposed animals with respect to total 
protein and LDH assays (data not shown).
MWCNTs. Neutrophils were significantly 
elevated in rats exposed to the highest dose of 
all types of MWCNTs (200 µg/rat) compared 
with controls (DM alone) (Figure 6). All three 
rat labs (RL1, RL2, and RL3) found a signifi-
cant dose-dependent effect of the MWCNTs 
at day 1 post exposure: The percentages of 
neutrophils were significantly elevated in the 
50-µg/rat and 200-µg/rat dose groups com-
pared with controls. Histological evalua-
tion of lung tissue sections demonstrated 
the presence of inflammatory cells within 
centri acinar regions similar to that observed 
in mice (data not shown). Two of three labs 
also observed a significant effect on neutro-
phils at the highest dose of O-MWCNTs 
at 21 days post exposure (data not shown). 
Although all of the labs found a significant 
increase in the percentage of neutro phils for 
the highest dose of P-MWCNTs (200 µg/rat) 
at 1 day post exposure, the percentage 
was lower for P-MWCNT than for the 
same dose of O-MWCNT or F-MWCNT 
[see Supplemental Material, Figure S2 
(http://dx.doi.org/10.1289/ehp.1205693)]. 
Two of three labs observed a small but sig-
nificant effect in the high-dose P-MWCNT 
group at 21 days post exposure. The percent-
age of neutrophils in BALF of rats exposed to 
F-MWCNTs was significantly elevated at the 
highest dose in all labs at day 1 post exposure, 
but the neutrophilia was reduced compared 
with O-MWCNTs at 1 day post exposure 
and with O-MWCNTs and P-MWCNTs 
at 21 days post exposure. Interlaboratory pre-
cision was high enough to combine results 
from labs. This permitted a MWCNT toxicity 
ranking [see Supplemental Material, Figure S2 
(http://dx.doi.org/10.1289/ehp.1205693)], 
which showed that at the 200-µg dose at 
1 day post exposure, O-MWCNTs and 
F-MWCNTs caused stronger neutrophilic 
influx than the P-MWCNTs. At 21 days 
post exposure, there was no significant dif-
ference between rats that received DM (con-
trol) or the highest dose of F-MWCNTs (see 
Supplemental Material, Figure S2). However, 
significant neutrophilia persisted at 21 days 
post exposure for rats exposed to the highest 
dose of O-MWCNTs and P-MWCNTs. No 
significant differences were observed between 
control and MWCNT-exposed rats with 
Figure 3. Stimulation of neutrophilic inflammation in the lungs of mice by O-MWCNT (A), P-MWCNT (B), or F-MWCNT (C) evaluated in four labs (ML1, ML2, ML3, 
ML4). Values shown are the mean ± SE percentage of neutro phils in BALF 1 day after exposure to DM only (control) or MWCNTs at 40 µg/50 µL. (A) Significant increase 
induced by O-MWCNT in all four labs. (B) Significant increase induced by P-MWCNT in two labs. (C) Significant increase induced by F-MWCNT in three labs, 
F-MWCNT albeit to a lesser extent than that induced by O-MWCNT.
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Figure 4. Results of lung histopathology (A), BAL cytospins (B), and immunohistochemistry (C) for mice 
exposed to DM only (control) or O-MWCNTs (40 μg/50 μL). Abbreviations: a, alveolus; AD, alveolar ducts; 
BV, blood vessel; TB, terminal bronchioles. (A) Histopathology showing lung inflammatory response to 
O-MWCNTs. Centriacinar bronchiolitis/alveolitis (dashed arrows) was induced by O-MWCNTs in three 
of four labs (ML1, ML2, ML3); one lab (ML4) found some deposition of O-MWCNTs in alveolar ducts with 
marginal inflammation. Solid arrows indicate macrophages containing O-MWCNT. (B) BAL cytospin 
images of cells from the lungs of mice exposed to DM (control) or O-MWCNTs; > 95% of macrophages from 
O-MWCNT–exposed animals were enlarged, activated alveolar macro phages with numerous MWCNT 
inclusions (solid arrows) and neutrophils that do not contain MWCNTs (dashed arrows). The images are 
from a single lab (ML3) but are typical of responses from ML1 and ML2. (C) Immunohistochemistry using a 
monoclonal rat anti-mouse neutrophil (allotypic marker clone 7/4) antibody showing the location of neutro-
phils (dashed arrows) near terminal bronchioles and in relation to macrophages containing O-MWCNT 
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respect to total protein and LDH assays (data 
not shown). Histopathological examination 
of the lungs demonstrated acute inflammatory 
lesions at 1 day post exposure, but no lasting 
changes were present at 21 days post exposure 
(data not shown).
Discussion
The results presented here represent the first 
attempt by an integrated consortium of inde-
pendent labs to determine whether the effects 
of well-characterized ENMs on pulmonary 
responses in mice and rats could be reliably 
reproduced by multiple investigators using 
a harmonized protocol. ENMs presented a 
challenge for inter laboratory comparisons 
because of the complexity of variables, includ-
ing dispersion and characterization. Despite 
variability between labs in end points such 
as cell counts and LDH and total protein in 
BALF, other end points revealed consistent 
patterns among labs and between rodent mod-
els, including neutrophilic inflammation (as 
a percentage of total cells), and pathologic 
responses in mice treated with TiO2-NBs or 
O-MWCNTs. Because inhalation is a pri-
mary route of exposure to particles, the lungs 
represent a major target organ for the toxic-
ity of ENMs from occupational, accidental, 
or environmental exposures (Kreyling et al. 
2010). In the present study, all of the labs 
used high bolus doses of ENMs that were 
delivered by either OPA in mice or IT in rats. 
This approach was not intended to mimic 
real-world exposure conditions or deposi-
tion patterns in the lung that would occur 
via inhalation. Instead, we sought to evaluate 
whether different labs could generate similar 
and reproducible results with ENMs. Further 
work should focus on results after inhalation 
exposure, which is more physio logi cally rele-
vant, to develop data for risk assessment and 
characterization to derive exposure standards.
The primary end point that was reliably 
reproducible in this inter laboratory effort was 
acute neutrophilia. However, the four mouse 
labs found different orders of potency for the 
three types of TiO2 nano particles. For exam-
ple, for day 1, ML1 showed that TiO2-P25 
produced the greatest level of neutrophilia, 
whereas ML3 showed that TiO2-NB caused 
the highest level of neutrophilia. TiO2-NBs 
were generally more toxic than TiO2 nano-
spheres—perhaps because of their shape—
and produced neutrophilia in nearly all 
labs. However, neutrophilia caused by TiO2 
nano particles did not persist at 7 days post-
exposure. Therefore, although acute inflam-
matory end points may not be the most 
useful for determining chronic disease such 
as fibrosis or carcinogenesis, acute inflamma-
tion is still the most sensitive end point for 
toxicity ranking. Future studies comparing 
spherical to high-aspect-ratio TiO2 should 
a) address clearance versus retention in the 
lungs after inhalation, b) evaluate pathologic 
changes over a period of weeks to months, 
and c) measure appropriate bio markers of 
fibro proliferative and neo plastic disease.
All of the labs observed similar acute 
inflammatory responses to MWCNTs in mice 
and rats, as indicated by significant neutro-
philic influx into the lungs of exposed ani-
mals and similar lung pathology. Three of 
four mouse labs found O-MWCNTs to be 
the most inflammatory, as indicated by neu-
trophil influx at 1 day post exposure, whereas 
F-MWCNTs were the least pro inflammatory. 
All  three rat labs also observed that 
O-MWCNTs were the most inflammatory 
[see Supplemental Material, Figure S2 (http://
dx.doi.org/10.1289/ehp.1205693)]. This judg-
ment about relative toxicological potency is 
based on the consistent findings of an onset of 
inflammation at a lower dose (i.e., 50 µg IT) 
combined with persistence of neutrophilia at 
21 days post exposure. Therefore, both mice 
and rats used in the consortium effort inde-
pendently identified O-MWCNTs as having 
the greatest pro inflammatory effect, suggest-
ing that residual catalytic metals [see Xia et al. 
(2013) for physicochemical charac terization] 
may have contributed to the inflammatory 
response. Moreover, the mouse and rat work-
ing groups observed similar pathology in ani-
mals exposed to O-MWCNTs. 
In retrospect, we can identify aspects of the 
study design that worked well and those that 
could be considered for improvement in future 
inter laboratory in vivo comparison studies with 
ENMs. The concordance in findings in terms 
of neutrophilia and histo patho logical changes 
that were detected with the TiO2-NBs and 
MWCNTs confirms the importance of care-
ful planning and lends strength to conclusions 
made about the relative acute potency of these 
materials. However, the variability found in 
the absolute number of neutrophils highlights 
some methodo logical differences that were not 
considered at the outset of the studies. Even 
though by design the rat and mouse groups 
used similar dispersion protocols to break up 
large agglomerates, it was beyond the scope of 
this project to ensure that all users had identi-
cal dispersion instrumentation. Thus, it was 
not technically possible to ensure that all labs 
delivered ENMs that were identical in particle 
size distribution. Approaches that have been 
recently described (Taurozzi et al. 2011, 2013) 
could be considered for future efforts, but 
Figure 5. Stimulation of neutrophilic inflammation in the lungs of rats by TiO2-P25 (A), TiO2-A (B), or TiO2-NB (C) evaluated in three labs (RL1, RL2, and RL3). Values are 
the mean ± SE percentage of neutro phils in BALF 1 day after exposure to DM only (control) or TiO2 ENMs (20, 70, or 200 µg/250 µL). 

















































Figure 6. Stimulation of neutrophilic inflammation in the lungs of rats by O-MWCNT (A), P-MWCNT (B), or F-MWCNT (C) evaluated in three labs (RL1, RL2, and 
RL3). Values are the mean ± SE percentage of neutro phils in BALF of rats 1 day after treatment with DM only (control) or MWCNTs (10, 50, or 200 µg/250 µL). 
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they were not available at the time the studies 
were conducted.
Other design problems to overcome 
include differences in instillation/aspiration 
and lavage techniques from one lab to another. 
Despite detailed planning, it was not realistic 
to mandate identical techniques across the labs 
because that would have involved significant 
expenditure of animals and time for training. 
It may not be possible to overcome these 
problems; thus, careful consideration should 
be given to the end points that can be reliably 
used for comparisons. Last, inherently low-
toxicity ENMs such as TiO2 are perhaps not 
as useful for inter laboratory comparisons as 
more potent materials. More specifically, 
the spherical TiO2 particles were not potent 
enough in these bioassays to be identified 
consistently across the labs as having acute 
in vivo toxicity upon bolus delivery. In 
contrast, the MWCNTs were sufficiently 
potent to be identified as potentially hazardous 
by all labs in this round-robin effort (i.e., 
sufficiently insensitive to the methodological 
differences among the labs).
It is important to note that pathology 
might be affected by nano particle delivery 
modes. The fibrotic response to MWCNTs 
in mice has been reported to be more diffuse 
in inhalation exposures compared with aspi-
ration exposure (Shvedova et al. 2008). The 
issue of MWCNT dispersion (i.e., agglomera-
tion state) and consequent disease is a critical 
one in assessing health risks. For example, 
inhalation of agglomerated MWCNTs causes 
a different pathology (less interstitial fibrosis) 
than dispersed fibrillar structures (Ma-Hock 
et al. 2009; Pauluhn 2010). Other recent 
studies (Porter et al. 2010; Wang et al. 
2011) reported that OPA aspiration of well-
dispersed MWCNTs caused more fibrosis 
and growth-factor production than did non-
dispersed MWCNTs. All of the labs in the 
consortium used the same dispersion medium 
for suspending MWCNTs or TiO2 nano -
particles. Nevertheless, it was apparent that 
some agglomeration occurred, particularly 
for MWCNTs. Future studies should care-
fully evaluate whether functionalization of 
MWCNTs or other ENMs influences 
agglomeration status and surface properties, 
which could in turn alter pathologic responses 
resulting from bolus delivery of particles to 
the lungs in a liquid suspension. Responses 
following more realistic and physiological 
inhalation exposures should be evaluated with 
these materials to confirm the hazard ranking 
and to derive the lowest or no-effect levels for 
purposes of risk charac terization, although 
that was not the purpose of the experiments 
presented here. 
MWCNTs and TiO2-NBs represent 
ENMs that are referred to as high-aspect-ratio 
nano particles (i.e., fiber-like structures that 
have nano scale width but can be micrometers 
in length). A principal charac teris tic of high-
aspect-ratio nano particles that is shared by 
pathogenic fibers, such as asbestos, is impeded 
clearance from the lungs after inhalation expo-
sure, which may lead to the patho genesis of 
diseases such as pulmonary fibrosis and meso-
thelioma (Bonner 2010). There is evidence 
that high-aspect-ratio TiO2-NBs and long 
MWCNTs are more patho genic and may elicit 
“frustrated phago cytosis” by macrophages, 
lysosomal disruption, and impaired clearance 
(Donaldson et al. 2011; Hamilton et al. 2009). 
Therefore, exposure to some of the ENMs used 
in this consortium study might be cause for 
concern about human health. 
Pulmonary toxicology studies in rodents 
have shown that OPA or IT exposure to 
MWCNTs at high doses/concentrations results 
in lung inflammation and interstitial pulmo-
nary fibrosis, similar to that of exposure to 
asbestos fibers (Han et al. 2010; Mercer et al. 
2011; Porter et al. 2010; Ryman-Rasmussen 
et al. 2009a; Wang et al. 2011). Inhaled 
MWCNTs can also cause inflammatory reac-
tions by migrating to the pleural membrane 
surrounding the lungs (Porter et al. 2010; 
Ryman-Rasmussen et al 2009b). Direct intra-
peritoneal injection of very high doses of other 
MWCNTs have also been reported to induce 
mesothelioma in genetically susceptible mice 
that lack an allele of the tumor suppressor p53 
(Takagi et al. 2008). Some caution should be 
taken in interpreting these latter results, because 
p53-deficient mice spontaneously develop 
tumors. In addition, a 2-year study showed 
that MWCNTs possessed no carcinogenicity 
when injected into the peritoneal cavity of male 
Wistar rats (Muller et al. 2009), although that 
study used very short MWCNTs (< 1 µm). 
However, the injection studies mentioned 
above did not address direct exposure to the 
lungs. It should also be stressed that it is unclear 
to what extent the differences in MWCNT 
properties (i.e., associated metal content, disper-
sion state/method, aspect ratio, rigidity) and 
means of exposure played a role in disparate 
outcomes. Therefore, it remains to be deter-
mined whether MWCNTs are carcinogenic in 
inhalation studies. 
Thus far, no human disease has been linked 
to exposure to carbon nano tubes. Therefore, 
the scientific community has a unique oppor-
tunity to address human health effects in a pre-
ventive manner and reduce potential adverse 
health effects by establishing assays to predict 
disease outcome using in vitro and in vivo 
models. This article on inter laboratory studies 
in rodents exposed to ENMs and the accom-
panying article on inter laboratory in vitro stud-
ies (Xia et al. 2013) comprise one of the first 
attempts to assess the reproducibility of experi-
ments among different labs using harmonized 
experimental protocols and identical ENMs.
Outlook and Future Directions
As part of the nano technology revolution, 
a vast array of industrial and consumer 
products is emerging on the market. Many 
nanomaterials are already in the marketplace 
in consumer products [a comprehensive list 
is maintained and updated by the Project on 
Emerging Technologies (2013)]. It is not 
feasible or practical to test all of these ENMs 
using in vivo rodent models. Therefore, 
predictive high throughput screening of 
materials using validated in vitro model 
systems, along with with more thorough analy-
ses of selected ENMs using realistic in vivo 
rodent models and realistic exposures, will 
likely be the only practical way to determine 
the toxic potential of an enormous variety 
of emerging nano materials (Nel et al. 
2009). Standard protocols should be used 
for in vitro screening and the resulting data 
made publicly available through a centralized 
database. In addition, a centralized repository 
for ENMs should be established to provide 
well-characterized ENMs in large quantities 
to investigators.
We are only beginning to understand 
the mechanisms of toxicity of the increasing 
variety of emerging ENMs. Growing evidence 
indicates that nano sizing particles increases 
toxicity because of a proportional increase in 
surface area that is then available to generate 
reactive oxygen species (ROS), primary factors 
that drive cellular stress and disease patho-
genesis (Nel et al. 2006). However, in addition 
to the obvious role of increased surface area 
and ROS generation, nano sized particles could 
be capable of moving across cellular barriers 
to interact with sub cellular structures (e.g., 
mitochondria, microtubules, organelles, DNA) 
in potentially unique ways that we do not yet 
fully comprehend. There is also evidence that 
ENMs traverse the pulmonary epithelial–
endothelial barrier to gain access to secondary 
target tissues (Aiso et al. 2011; Kreyling et al. 
2002, 2009). Alternatively, ENMs could 
influence immune responses of secondary 
target tissues by stimulating the release of 
lung cyto kines into the systemic circulation 
(Mitchell et al. 2007). Therefore, to keep pace 
with the emerging nano technology industry 
and associated human and environmental 
exposures, more research is required to 
elucidate common mechanisms of nano-
particle-induced adverse health effects. 
Unfortunately, the amount of funding 
for nano toxicology research on health effects 
lags far behind what is available for nano-
technology research and development. The 
disproportionate emphasis on nano technology 
research and development compared with 
issues of risk for human health and the 
environ ment could result in a new wave of 
occupa tional and environmental health crises. 
Although many ENMs will present little 
Bonner et al.
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or no risk, it is inevitable that at least some 
ENMs will pose a significant risk to human 
health and the environment. Our consortium 
experiments described here are significant in 
providing results of a coordinated effort toward 
addressing hazard identification of high-
priority ENMs. Future research should expand 
this consortium effort to allow for toxicity 
testing and exposure assessment to ensure 
the safe continuation and economic viability 
of nano technology.
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